InspireMD announces approval of IDE application for CGUARDIANS II study
PremiumThe FlyInspireMD announces approval of IDE application for CGUARDIANS II study
1M ago
InspireMD Advances with FDA Study Approval and Global Goals
Premium
Company Announcements
InspireMD Advances with FDA Study Approval and Global Goals
1M ago
InspireMD Launches 2024 Plan to Attract Talent with Stock
Premium
Company Announcements
InspireMD Launches 2024 Plan to Attract Talent with Stock
1M ago
NSPR Earnings this Week: How Will it Perform?
PremiumPre-EarningsNSPR Earnings this Week: How Will it Perform?
3M ago
InspireMD Secures Funds to Expand Healthcare Innovations
Premium
Company Announcements
InspireMD Secures Funds to Expand Healthcare Innovations
4M ago
InspireMD announce full exercise of warrant tranche for $17.9M in proceeds
Premium
The Fly
InspireMD announce full exercise of warrant tranche for $17.9M in proceeds
4M ago
InspireMD reports Q1 EPS (21c) vs (53c) last year
PremiumThe FlyInspireMD reports Q1 EPS (21c) vs (53c) last year
6M ago
NSPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
NSPR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
InspireMD Boosts Executive Severance Benefits Ahead of Potential Takeover
Premium
Company Announcements
InspireMD Boosts Executive Severance Benefits Ahead of Potential Takeover
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100